Document Detail


Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
MedLine Citation:
PMID:  7498288     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To investigate the role of serotonin (5-hydroxytryptamine; 5-HT) receptors in the modulation of rat thalamocortical oscillations, we studied the effects of 5-HT1/5-HT2 receptor subtype specific drugs on neocortical high-voltage spindle activity in adult male rats. A 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) (0.03, 0.1, 0.3 and 1.0 mg/kg s.c.), had no effect on neocortical high-voltage spindle activity. Furthermore, a mixed 5-HT1/5-HT2 receptor antagonist, methysergide (1.0, 5.0 and 15.0 mg/kg i.p.), had no effect, whereas a non-specific mixed 5-HT1/5-HT2 receptor antagonist, methiothepin (0.2, 1.0 and 5.0 mg/kg i.p.), significantly increased neocortical high-voltage spindles. Of the 5-HT2 receptor antagonists, ritanserin (0.1, 1.0 and 5.0 mg/kg s.c.) had no effect, whereas ketanserin (1.0, 5.0 and 20.0 mg/kg s.c.) increased neocortical high-voltage spindles, but only at the highest dose used. A 5-HT2 receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) (0.5, 1.0 and 2.0 mg/kg s.c.), at the two highest doses significantly decreased neocortical high-voltage spindle activity, and this effect was blocked by the 5-HT2 receptor antagonists, ketanserin (1.0, 5.0 and 20.0 mg/kg s.c.) and ritanserin (1.0 and 5.0 mg/kg s.c.), as well as by methiothepin (0.2, 1.0 and 5.0 mg/kg i.p.) and methysergide (1.0, 5.0 and 15.0 mg/kg i.p.). Furthermore, unilateral intrathalamic infusions, but not intrahippocampal control infusions, of DOI (10 and 50 micrograms/1.0 microliters/rat) decreased neocortical high-voltage spindle activity and systemic administration of ketanserin (20.0 mg/kg s.c.) completely blocked this effect. The present results suggest that (1) the serotonergic system modulates rat thalamocortical oscillations as measured by neocortical high-voltage spindle activity, (2) activation of 5-HT2 receptors, possibly located in the thalamus, with a specific 5-HT2 receptor agonist, DOI, causes a reduction in rat neocortical high-voltage spindle activity.
Authors:
P Jäkälä; J Sirviö; E Koivisto; M Björklund; J Kaukua; P Riekkinen
Related Documents :
9652358 - Mdma ('ecstasy') enhances 5-ht1a receptor density and 8-oh-dpat-induced hypothermia: bl...
15708488 - Effects of injections of 8-hydroxy-2-(di-n-propylamino)tetralin or muscimol in the medi...
8808148 - Effects of the serotonin receptor agonists 8-oh-dpat and tfmpp on learning as assessed ...
14674858 - Castration reduces the effect of serotonin-1a receptor stimulation on prepulse inhibiti...
7191788 - Characterization of the natriuretic activity in the plasma of hypervolaemic rats.
22997198 - Preservation of hepatic blood flow by direct peritoneal resuscitation improves survival...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of pharmacology     Volume:  282     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1996-01-18     Completed Date:  1996-01-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  39-55     Citation Subset:  IM    
Affiliation:
Department of Neurology, University of Kuopio, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
Amphetamines / pharmacology*
Analysis of Variance
Animals
Cerebral Cortex / drug effects*
Electroencephalography / drug effects*
Infusions, Parenteral
Ketanserin / pharmacology
Male
Methiothepin / pharmacology
Methysergide / pharmacology
Neural Pathways / drug effects
Rats
Rats, Wistar
Receptors, Serotonin / drug effects*,  physiology
Ritanserin / pharmacology
Thalamus / drug effects*
Chemical
Reg. No./Substance:
0/Amphetamines; 0/Receptors, Serotonin; 20229-30-5/Methiothepin; 361-37-5/Methysergide; 64584-34-5/4-iodo-2,5-dimethoxyphenylisopropylamine; 74050-98-9/Ketanserin; 78950-78-4/8-Hydroxy-2-(di-n-propylamino)tetralin; 87051-43-2/Ritanserin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine,...
Next Document:  Characterisation of functional endothelin receptors in the canine isolated perfused spleen.